Low collagen levels signal hidden heart disease risk in middle-aged adults
A Swedish study of over 1,000 people found that those with low circulating collagen markers were significantly more likely to have undetected coronary atherosclerosis. The discovery could enable earlier screening and intervention for heart disease, potentially reshaping cardiovascular risk assessment and diagnostic protocols across preventive medicine.
Originaltitel: Circulating type I collagen pro-a1 chain is inversely associated with the presence of coronary atherosclerosis in a Swedish middle-aged population
<p>The turnover of type I collagen plays an important role in atherogenesis and atherothrombosis. The pro-alpha 1(I) chain of type I collagen (COL1 alpha 1) has emerged as a novel circulating biomarker associated with coronary artery disease (CAD) events. This study aimed to investigate the association between circulating COL1 alpha 1 and coronary atherosclerosis in a middle-aged general population. Participants (n = 1 078) were randomly recruited from the Link & ouml;ping branch of the Swedish Cardiopulmonary Bioimage Study (SCAPIS) comprising an equal number of men and women 50-64 years old. Coronary artery calcium scores were calculated from non-contrast computed tomography (CT) while coronary stenosis, presence of plaques and segmental involvement scores were derived from coronary CT angiography. COL1 alpha 1, interleukin-6 and matrix metalloproteinase-9 were quantified in plasma. Binary logistic regression models were used. Participants with low COL1 alpha 1 levels exhibited a more unfavorable cardiovascular risk profile. There was an inverse association between COL1 alpha 1 and all measures of coronary atherosclerosis before adjustment (ORrange=0.50-0.73, p &lt; 0.05 for all). In two multivariable models adjusting for potential confounders and CAD risk factors, an association with coronary stenosis &gt;= 50% (OR = 0.61 and 0.59, respectively) and non-calcified atherosclerotic plaques (OR = 0.62 for both) remained (p &lt; 0.05 for all). The findings shed further light on COL1 alpha 1 as a potential CAD biomarker.</p>